Yoshitaka Tamura

发表

Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study

Hidekazu Suzuki, A. Nishitani, M. Fujishima, 2018, BMC Cancer.

Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents.

Satomu Morita, Hidekazu Suzuki, T. Hirashima, 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Prompt Reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19

Toshio Tanaka, T. Shioda, K. Yoshizaki, 2021, Frontiers in Medicine.

Simultaneous and Longitudinal Comparison of Interferon Gamma Release Assay Data from Health Care Workers in Japan

Koichi Suzuki, Y. Hoshino, Tomoshige Matsumoto, 2013 .

Development of an efficient one-step real-time reverse transcription polymerase chain reaction method for severe acute respiratory syndrome-coronavirus-2 detection

S. Fujiwara, K. Yasukawa, S. Ida, 2021, PloS one.

Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective study

I. Kawase, Hidekazu Suzuki, M. Fujishima, 2014, BMC Cancer.

The Characteristics of People Requesting HIV Antibody Tests at Public Health Centers in Japan

S. Hashimoto, S. Tanihara, Emi Shimazaki, 2005, Journal of epidemiology.

Clinical COVID-19 diagnostic methods: Comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR)

Toshio Tanaka, T. Hirashima, H. Matsuoka, 2021, Journal of Clinical Virology.

Significance of Quantitative Interferon-gamma Levels in Non-small-cell Lung Cancer Patients' Response to Immune Checkpoint Inhibitors

Toshio Tanaka, Hidekazu Suzuki, K. Kawahara, 2020, AntiCancer Research.

The Levels of Interferon-gamma Release as a Biomarker for Non-small-cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

Toshio Tanaka, Hidekazu Suzuki, K. Kawahara, 2019, AntiCancer Research.

Transbronchial Cryobiopsy for Miliary Tuberculosis Mimicking Hypersensitivity Pneumonitis

Hidekazu Suzuki, K. Kawahara, T. Hirashima, 2020, Internal medicine.

[Molecular epidemiology of tuberculosis by the use of IS6110 restriction fragment length polymorphism: a study from 2001 to 2003].

K. Kawahara, K. Nishimori, H. Ano, 2006, Kekkaku : [Tuberculosis].

Tuberculosis infection among homeless persons and caregivers in a high-tuberculosis-prevalence area in Japan: a cross-sectional study

T. Tabuchi, H. Iso, T. Takatorige, 2011, BMC infectious diseases.

Significance of Pre-treatment Interferon-gamma Release in Patients With Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitors

Hidekazu Suzuki, K. Kawahara, T. Hirashima, 2020, AntiCancer Research.